Matches in SemOpenAlex for { <https://semopenalex.org/work/W2380610267> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2380610267 endingPage "30" @default.
- W2380610267 startingPage "224" @default.
- W2380610267 abstract "To investigate the expression of mitogen activated protein kinase phosphatase-1 (MKP-1) and phosphorylation extracellular signal-regulated kinases (p-ERK(1/2)) in primary ovarian epithelial tumor tissues, and provide experiment's foundation on the new treatment in ovarian cancer. Expression of MKP-1 and p-ERK(1/2) in tissues from 64 patients with primary ovarian epithelial tumor, 35 patients with ovarian epithelial bordline tumor, 32 patients with ovarian epithelial benign tumor and 26 normal ovarian tissues was detected by immunohistochemistry. Western-blot was also used for detecting the expression of MKP-1 and p-ERK(1/2) protein in these tissues. Immunohistochemistry and Western-blot assay showed that the expression of MKP-1 was gradually decreased in normal ovarian tissues, benign tumor, bordline tumor and carcinoma respectively, and there were significant differences among them (P < 0.01). The MKP-1 expression level in the carcinoma tissues of stage III/IV patients was significantly lower than that of stage I/II patients. However, the expression of p-ERK(1/2) was gradually increased in normal ovarian tissues, benign tumor, bordline tumor and carcinoma respectively, and there were also significant differences among them (P < 0.01), the p-ERK(1/2) expression level in the carcinoma tissues of stage III/IV patients was significantly higher than that of stage I/II patients. Expression of MKP-1 and p-ERK(1/2) in same ovarian carcinoma tissues detected by immunohistochemistry and Western-blot assay showed significant negative correlation (r = -0.90, P < 0.01 and r = -0.78, P < 0.01 respectively). The expression changes of MKP-1 and ERKs may play a role in the development of ovarian carcinoma. The abnormal expression of MKP-1 and p-ERK(1/2) probably assists in promoting the development and progression of ovarian carcinoma." @default.
- W2380610267 created "2016-06-24" @default.
- W2380610267 creator A5002560091 @default.
- W2380610267 creator A5017083843 @default.
- W2380610267 creator A5064102449 @default.
- W2380610267 date "2009-06-01" @default.
- W2380610267 modified "2023-09-23" @default.
- W2380610267 title "[The expression of MKP-1 and p-ERK(1/2) in primary ovarian epithelial tumor tissues]." @default.
- W2380610267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19697705" @default.
- W2380610267 hasPublicationYear "2009" @default.
- W2380610267 type Work @default.
- W2380610267 sameAs 2380610267 @default.
- W2380610267 citedByCount "2" @default.
- W2380610267 countsByYear W23806102672019 @default.
- W2380610267 countsByYear W23806102672020 @default.
- W2380610267 crossrefType "journal-article" @default.
- W2380610267 hasAuthorship W2380610267A5002560091 @default.
- W2380610267 hasAuthorship W2380610267A5017083843 @default.
- W2380610267 hasAuthorship W2380610267A5064102449 @default.
- W2380610267 hasConcept C104317684 @default.
- W2380610267 hasConcept C121608353 @default.
- W2380610267 hasConcept C126322002 @default.
- W2380610267 hasConcept C134018914 @default.
- W2380610267 hasConcept C142724271 @default.
- W2380610267 hasConcept C184235292 @default.
- W2380610267 hasConcept C204232928 @default.
- W2380610267 hasConcept C2776415932 @default.
- W2380610267 hasConcept C2777546739 @default.
- W2380610267 hasConcept C2778324911 @default.
- W2380610267 hasConcept C2780084626 @default.
- W2380610267 hasConcept C2780427987 @default.
- W2380610267 hasConcept C3019054536 @default.
- W2380610267 hasConcept C502942594 @default.
- W2380610267 hasConcept C55493867 @default.
- W2380610267 hasConcept C57074206 @default.
- W2380610267 hasConcept C71924100 @default.
- W2380610267 hasConcept C86803240 @default.
- W2380610267 hasConcept C95444343 @default.
- W2380610267 hasConceptScore W2380610267C104317684 @default.
- W2380610267 hasConceptScore W2380610267C121608353 @default.
- W2380610267 hasConceptScore W2380610267C126322002 @default.
- W2380610267 hasConceptScore W2380610267C134018914 @default.
- W2380610267 hasConceptScore W2380610267C142724271 @default.
- W2380610267 hasConceptScore W2380610267C184235292 @default.
- W2380610267 hasConceptScore W2380610267C204232928 @default.
- W2380610267 hasConceptScore W2380610267C2776415932 @default.
- W2380610267 hasConceptScore W2380610267C2777546739 @default.
- W2380610267 hasConceptScore W2380610267C2778324911 @default.
- W2380610267 hasConceptScore W2380610267C2780084626 @default.
- W2380610267 hasConceptScore W2380610267C2780427987 @default.
- W2380610267 hasConceptScore W2380610267C3019054536 @default.
- W2380610267 hasConceptScore W2380610267C502942594 @default.
- W2380610267 hasConceptScore W2380610267C55493867 @default.
- W2380610267 hasConceptScore W2380610267C57074206 @default.
- W2380610267 hasConceptScore W2380610267C71924100 @default.
- W2380610267 hasConceptScore W2380610267C86803240 @default.
- W2380610267 hasConceptScore W2380610267C95444343 @default.
- W2380610267 hasIssue "3-4" @default.
- W2380610267 hasLocation W23806102671 @default.
- W2380610267 hasOpenAccess W2380610267 @default.
- W2380610267 hasPrimaryLocation W23806102671 @default.
- W2380610267 hasRelatedWork W2032360738 @default.
- W2380610267 hasRelatedWork W2348060875 @default.
- W2380610267 hasRelatedWork W2351047624 @default.
- W2380610267 hasRelatedWork W2353270333 @default.
- W2380610267 hasRelatedWork W2357959097 @default.
- W2380610267 hasRelatedWork W2372697361 @default.
- W2380610267 hasRelatedWork W2373788842 @default.
- W2380610267 hasRelatedWork W2376682261 @default.
- W2380610267 hasRelatedWork W2378282859 @default.
- W2380610267 hasRelatedWork W2380610267 @default.
- W2380610267 hasVolume "42" @default.
- W2380610267 isParatext "false" @default.
- W2380610267 isRetracted "false" @default.
- W2380610267 magId "2380610267" @default.
- W2380610267 workType "article" @default.